Veeva Systems
VEEV
282.50
-1.00
-0.35%
Veeva Systems
US · VEEV
#470 by market cap
Listed 1970
282.50
-1.00
-0.35%
Live - 5344 symbols - heartbeat 164s ago
· 2026-10-08 08:22
Pre-market
283.28
+0.28%
After-hours
283.03
+0.19%
Overnight
282.50
0.00%
- Market cap
- 45.74B
- P/E (TTM)i
- 46.31
- P/Bi
- 6.15
- EPSi
- 5.44
- Div yieldi
- 0.00%
- 52W posi
- 87%
Reader sentiment
Are you bullish or bearish on VEEV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 17.78, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +16.34% YoY
Margins
- Gross margin
- 75.53%
- Operating margin
- 28.68%
- Net margin
- 28.45%
Key ratios & quality
- PEG ratioi
- 2.01
- Altman Z-Scorei
- 17.78
PEG uses trailing P/E against the 3-year net income growth rate (23.06%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 862.21M | 1.10B | 1.47B | 1.85B | 2.16B | 2.36B | 2.75B | 3.20B |
| Gross profit | 616.93M | 800.71M | 1.06B | 1.35B | 1.55B | 1.69B | 2.05B | 2.41B |
| Selling & admin expenses | 235.28M | 304.60M | 384.13M | 459.57M | 566.29M | 628.02M | 662.47M | 729.54M |
| Research & development | 158.78M | 209.90M | 294.22M | 382.04M | 520.28M | 629.03M | 693.08M | 767.39M |
| Operating profit | 222.87M | 286.22M | 377.79M | 505.50M | 459.09M | 429.33M | 691.44M | 916.37M |
| Pretax profit | 238.64M | 313.70M | 393.99M | 512.31M | 509.10M | 588.02M | 919.38M | 1.19B |
| Tax | 8.81M | 12.58M | 14.00M | 84.92M | 21.39M | 62.32M | 205.24M | 285.60M |
| Net profit | 229.83M | 301.12M | 380.00M | 427.39M | 487.71M | 525.71M | 714.14M | 908.91M |
| Basic EPS | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 6 |
| Diluted EPS | 1.47 | 1.90 | 2.36 | 2.63 | 3.00 | 3.22 | 4.32 | 5.44 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 759.04M | 789.08M | 811.24M | 835.95M | 882.95M | 927.96M |
| Gross profit | 585.22M | 593.83M | 611.77M | 622.47M | 662.02M | 695.95M |
| Selling & admin expenses | 167.45M | 205.24M | 179.04M | 177.81M | 180.59M | 198.02M |
| Research & development | 184.03M | 192.68M | 191.88M | 198.79M | 208.32M | 222.92M |
| Operating profit | 233.73M | 195.91M | 240.85M | 245.88M | 273.11M | 275.02M |
| Pretax profit | 298.82M | 265.36M | 312.79M | 317.54M | 347.53M | 349.53M |
| Tax | 70.63M | 65.06M | 76.58M | 73.33M | 86.59M | 76.10M |
| Net profit | 228.19M | 200.31M | 236.20M | 244.20M | 260.94M | 273.43M |
| Basic EPS | 1 | 1 | 1 | 1 | 2 | 2 |
| Diluted EPS | 1.37 | 1.19 | 1.40 | 1.45 | 1.57 | 1.66 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.43B | 1.53B | 2.31B | 3.11B | 3.97B | 5.00B | 6.31B | 8.00B |
| Cash & ST investments | 1.09B | 1.09B | 1.66B | 2.38B | 3.10B | 4.03B | 5.15B | 6.56B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.65B | 2.27B | 3.05B | 3.82B | 4.80B | 5.91B | 7.34B | 8.98B |
| Total current liabilities | 401.02M | 551.17M | 715.95M | 840.78M | 1.01B | 1.18B | 1.40B | 1.64B |
| Short-term debt | -- | 10.01M | 11.73M | 10.98M | 11.31M | 9.33M | 9.97M | 12.15M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 416,017,000.00 | 606,183,000.00 | 779,747,000.00 | 904,828,000.00 | 1,088,044,000.00 | 1,266,096,000.00 | 1,507,383,000.00 | 1,764,591,000.00 |
| Total equity | 1.24B | 1.67B | 2.27B | 2.91B | 3.72B | 4.64B | 5.83B | 7.21B |
| Retained earnings | 619.20M | 919.66M | 1.30B | 1.73B | 2.21B | 2.74B | 3.45B | 4.36B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 6.71B | 6.99B | 7.11B | 8.00B | 8.06B | 7.95B |
| Cash & ST investments | 6.07B | 6.40B | 6.64B | 6.56B | 7.31B | 7.24B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 7.77B | 8.00B | 8.10B | 8.98B | 9.13B | 9.06B |
| Total current liabilities | 1.46B | 1.26B | 944.88M | 1.64B | 1.70B | 1.46B |
| Short-term debt | 10.67M | 10.66M | 10.53M | 12.15M | 13.13M | 14.64M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,553,979,000.00 | 1,360,888,000.00 | 1,056,520,000.00 | 1,764,591,000.00 | 1,825,204,000.00 | 1,628,774,000.00 |
| Total equity | 6.21B | 6.64B | 7.04B | 7.21B | 7.30B | 7.43B |
| Retained earnings | 3.68B | 3.88B | 4.12B | 4.36B | 4.62B | 4.90B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 310.83M | 437.38M | 551.25M | 764.46M | 780.47M | 911.34M | 1.09B | 1.42B |
| Depreciation & amortization | 14.07M | 19.86M | 29.46M | 27.45M | 29.12M | 32.63M | 39.38M | 37.97M |
| Free cash flow | 310.83M | 437.38M | 551.25M | 764.46M | 780.47M | 911.34M | 1.09B | 1.42B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | 0 | 0 | -169.95M |
| Ending cash balance | 552.18M | 479.80M | 731.71M | 1.14B | 889.65M | 706.67M | 1.12B | 1.42B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 877.16M | 238.43M | 192.79M | 106.85M | 1.13B | 238.71M |
| Depreciation & amortization | 9.82M | 10.13M | 9.71M | 8.32M | 11.59M | 10.87M |
| Free cash flow | 877.16M | 238.43M | 192.79M | 106.85M | 1.13B | 238.71M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | -226.95M | -245.73M |
| Ending cash balance | 1.97B | 1.93B | 1.66B | 1.42B | 1.90B | 1.81B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 21.79 | 20.74 | 19.33 | 16.51 | 14.72 | 12.58 | 13.63 | 13.93 |
| ROA %i | 16.12 | 15.34 | 14.29 | 12.46 | 11.31 | 9.81 | 10.78 | 11.14 |
| ROIC %i | 20.39 | 18.38 | 18.01 | 15.68 | 13.16 | 9.58 | 10.42 | 10.68 |
| 5-year avg ROE %i | 15.57 | 17.38 | 18.86 | 19.48 | 18.55 | 16.77 | 15.35 | 14.27 |
| EBIT margin %i | 25.85 | 25.92 | 25.79 | 27.31 | 21.30 | 18.16 | 25.17 | 28.68 |
| FCF / sales %i | 34.91 | 39.22 | 37.63 | 41.31 | 36.22 | 38.56 | 39.69 | 44.29 |
| Current ratioi | 3.57 | 2.78 | 3.23 | 3.70 | 3.94 | 4.24 | 4.51 | 4.89 |
| Quick ratioi | 3.52 | 2.74 | 3.18 | 3.65 | 3.86 | 4.17 | 4.44 | 4.81 |
| Debt / assetsi | 0.00 | 2.41 | 2.07 | 1.43 | 1.27 | 0.94 | 1.03 | 1.07 |
| LT debt / equityi | -- | 2.69 | 2.27 | 1.50 | 1.34 | 1.00 | 1.13 | 1.16 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 28.20 | 26.11 | 28.49 | 29.00 | 24.97 | 17.29 | 14.06 | 14.03 |
| Net income CAGR (3Y) %i | 61.60 | 57.16 | 35.97 | 22.97 | 17.44 | 11.43 | 18.66 | 23.06 |
| FCF CAGR (3Y) %i | 74.99 | 47.42 | 35.40 | 34.98 | 21.29 | 18.24 | 12.55 | 21.94 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 14.07 | 13.70 | 13.72 | 13.93 | 13.93 | 14.42 |
| ROA %i | 11.19 | 11.30 | 11.83 | 11.14 | 11.15 | 11.90 |
| ROIC %i | 13.90 | 13.54 | 13.54 | 10.68 | 13.75 | 14.19 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 26.97 | 26.93 | 27.88 | 28.68 | 28.79 | 29.93 |
| FCF / sales %i | 42.16 | 45.46 | 44.73 | 44.29 | 50.17 | 48.16 |
| Current ratioi | 4.60 | 5.57 | 7.53 | 4.89 | 4.74 | 5.46 |
| Quick ratioi | 4.54 | 5.48 | 7.42 | 4.81 | 4.67 | 5.36 |
| Debt / assetsi | 0.99 | 1.07 | 1.11 | 1.07 | 1.13 | 1.67 |
| LT debt / equityi | 1.07 | 1.13 | 1.13 | 1.16 | 1.23 | 1.84 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Subscription is the largest reported line at 82.63% of revenue, across 2 reported segments.
- The next-largest line, Professional services and other, is a distant second at 17.37% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Subscription82.63%
Professional services and other17.37%
Quote time 2026-10-08 08:22:26 · For reference only, not investment advice and not tailored to your situation.